Inclusion Criteria

INCLUSION CRITERIA:

- Clinician recommends repeat biopsy of the prostate ("Repeat" is defined as any
recommended biopsy of the prostate subsequent to an earlier biopsy of the prostate)

EXCLUSION CRITERIA:

- Definitive invasive prostate cancer on initial biopsy

- Significant active medical illness that in the opinion of the clinician would
preclude protocol treatment.

- History of ventricular tachycardia or ventricular fibrillation

- Subject reported use of fish oil (greater than 1 gram per day) or green tea
supplement within 30 days before Day 1 of study treatment

- Subject reported use of fish oil ≤ 1 gram per day and unwilling to discontinue use
for the duration of the trial

- Use of warfarin or need for therapeutic anticoagulation at time of biopsy or at
anytime during the course of the trial.

- Subject reported allergy or sensitivity to fish oil, olive oil or green tea

- Subject reported history of hemophilia, van Willebrands disease or other bleeding
disorder, except when the subject is evaluated by a hematologist who determines that
fish oil supplementation is not contraindicated.

- Total bilirubin greater than institutional upper limit of normal

- Concurrent high risk study participation